Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
about
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.
P2860
Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
@ast
Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
@en
type
label
Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
@ast
Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
@en
prefLabel
Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
@ast
Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
@en
P2093
P2860
P356
P1476
Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
@en
P2093
Abdulaziz Alshaer
Ben Horrocks
Bushra T Al-Quadeib
Elaine Mutch
Lidija Siller
Mahasen A Radwan
P2860
P304
P356
10.1002/BMC.3198
P577
2014-04-14T00:00:00Z